Previous reports indicate that CD4+CD161+ T cells represent a subset of fast acting T cells that inhibit mycobacterial growth in unexposed humans but not TB patients (67) and are also significantly reduced in active TB compared to latent TB (68), suggesting their protective immunity against Mtb infection. Here, KLRB1 is linked to tuberculosis.